Free Trial

4D Molecular Therapeutics (FDMT) Earnings Date, Estimates & Call Transcripts

$26.94
-0.28 (-1.03%)
(As of 01:51 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(May. 21)
-$0.66 Beat By $0.07
Consensus EPS
(May. 21)
-$0.73
Skip Charts & View Estimated and Actual Earnings Data

FDMT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FDMT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

4D Molecular Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.69)($0.69)($0.69)
Q2 20242($0.71)($0.68)($0.70)
Q3 20242($0.74)($0.68)($0.71)
Q4 20242($0.78)($0.67)($0.73)
FY 20247($2.92)($2.72)($2.82)

FDMT Earnings Date and Information

4D Molecular Therapeutics last released its quarterly earnings data on May 21st, 2024. The reported ($0.66) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.73) by $0.07. The business earned $0.03 million during the quarter, compared to analysts' expectations of $1.44 million. 4D Molecular Therapeutics has generated ($2.44) earnings per share over the last year (($2.44) diluted earnings per share). Earnings for 4D Molecular Therapeutics are expected to decrease in the coming year, from ($2.98) to ($3.09) per share. 4D Molecular Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.

4D Molecular Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2024
(Estimated)
------- 
5/21/2024-($0.73)($0.66)+$0.07($0.66)$1.44 million$0.03 million
5/9/2024Q1 2024($0.73)($0.66)+$0.07($0.66)$1.44 million$0.03 million
2/29/2024Q4 2023($0.68)($0.77)($0.09)($0.77)$4.67 million($0.02) million
11/9/2023Q3 2023($0.67)($0.24)+$0.43($0.24)$6.41 million$20.20 million
8/9/2023Q2 2023($0.77)($0.77)-($0.77)$1.43 million$0.24 million
5/10/2023Q1 2023($0.88)($0.88)-($0.88)$1.45 million$0.30 million
3/15/2023Q4 2022($0.75)($0.84)($0.09)($0.84)$4.97 million$1.25 million
11/8/2022Q3 2022($0.85)($0.79)+$0.06($0.79)$1.70 million$0.50 million
8/11/2022Q2 2022($0.78)($0.87)($0.09)($0.87)$3.00 million$0.16 million
5/12/2022Q1 2022($0.73)($0.82)($0.09)($0.82)$2.00 million$1.22 million    
3/28/2022Q4 2021($0.82)($0.85)($0.03)($0.85)$2.00 million$0.09 million
11/10/2021Q3 2021($0.81)($0.82)($0.01)($0.82)-$1.37 million
8/11/2021Q2 2021($0.68)($0.28)+$0.40($0.28)-$14.58 million    
5/12/2021Q1($1.10)($0.61)+$0.49($0.61)-$2.00 million

4D Molecular Therapeutics Earnings - Frequently Asked Questions

When is 4D Molecular Therapeutics's earnings date?

4D Molecular Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on FDMT's earnings history.

Did 4D Molecular Therapeutics beat their earnings estimates last quarter?

In the previous quarter, 4D Molecular Therapeutics (NASDAQ:FDMT) reported ($0.66) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.73) by $0.07. Learn more on analysts' earnings estimate vs. FDMT's actual earnings.

How much revenue does 4D Molecular Therapeutics generate each year?

4D Molecular Therapeutics (NASDAQ:FDMT) has a recorded annual revenue of $20.72 million.

How much profit does 4D Molecular Therapeutics generate each year?

4D Molecular Therapeutics (NASDAQ:FDMT) has a recorded net income of -$100.84 million. FDMT has generated -$2.44 earnings per share over the last four quarters.

What is 4D Molecular Therapeutics's EPS forecast for next year?

4D Molecular Therapeutics's earnings are expected to decrease from ($2.98) per share to ($3.09) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:FDMT) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners